How much is Hinge Bio worth in 2026?

Hinge Bio has a current valuation of $46.0M based on their Later Stage VC round and secondary market data.

How much funding has Hinge Bio raised?

Hinge Bio has raised $66.8M in total funding across 1 funding rounds.

Hinge Bio

Drug DiscoveryWebsite

Hinge Bio valuation and funding history | Last updated: January 15, 2025 | 1 funding rounds

Current Valuation

$46.0M

As of January 15, 2025

Total Funding Raised

$66.8M

Across 1 round

Last Round

Later Stage VC

$30.6M

Last Funding

Jan 2025

Funding date

Capital Efficiency

0.69x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
April 18, 2017	Accelerator/Incubator	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Hinge Bio is currently valued at $46.0M as of January 15, 2025. The company has raised a total of $66.8M in funding across 1 funding round.

Capital Efficiency

With a capital efficiency ratio of 0.69x, Hinge Bio has achieved a valuation that is 0.69 times the total capital raised.

Track Hinge Bio Valuation Updates

Get notified when Hinge Bio raises new funding or valuation changes

Explore More Data

Detailed analysis for Hinge Bio

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Hinge Bio's valuation history, funding rounds, and growth metrics.

No credit card required

What is Hinge Bio Worth in 2026?

Hinge Bio is a leading private company in the Drug Discovery sector. Track Hinge Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Hinge Bio Valuation is Determined

Private company valuations like Hinge Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.